Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated With PS-1 Mutations

Campion, 1999, Early-onset autosomal-dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum, Am J Hum Genet, 65, 664, 10.1086/302553 Cruts, 1998, Estimation of the genetic contribution of presenilin-1 and −2 mutations in a population-based study of presenile Alzheimer disease, Hum Mol Genet, 7, 43, 10.1093/hmg/7.1.43 Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375, 754, 10.1038/375754a0 Levy-Lahad, 1995, Candidate gene for the Chromosome 1 familial Alzheimer's disease locus, Science, 269, 973, 10.1126/science.7638622 Rogaev, 1995, Familial Alzheimer's disease in kindreds with missense mutations in a gene on Chromosome 1 related to the Alzheimer's disease Type 3 gene, Nature, 376, 775, 10.1038/376775a0 Sherrington, 1996, Alzheimer's disease associated with mutations in presenilin-2 is rare and variably penetrant, Hum Mol Genet, 5, 985, 10.1093/hmg/5.7.985 Tanzi, 1992, Assessment of amyloid β-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases, Am J Hum Genet, 1, 273 Lleó, 2002, Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer's disease in Spain, Arch Neurol, 59, 1759, 10.1001/archneur.59.11.1759 Janssen, 2003, Early-onset familial Alzheimer's disease: mutation frequency in 31 families, Neurology, 60, 235, 10.1212/01.WNL.0000042088.22694.E3 Cruts, 1998, Molecular genetics of Alzheimer's disease, 155 Gomez-Isla, 1999, The impact of different presenilin-1 and presenilin-2 mutations on amyloid deposition, neurofibrillary changes, and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors, Brain, 122, 1709, 10.1093/brain/122.9.1709 Lippa, 2000, Familial Alzheimer's disease: site of mutation influences clinical phenotype, Ann Neurol, 48, 376, 10.1002/1531-8249(200009)48:3<376::AID-ANA13>3.0.CO;2-U Scheuner, 1996, Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin-1 and −2 and APP mutations linked to familial Alzheimer's disease, Nat Med, 2, 864, 10.1038/nm0896-864 Mehta, 1998, Increased ABeta42(43) from cell lines expressing presenilin-1 mutations, Ann Neurol, 43, 256, 10.1002/ana.410430217 Duff, 1996, Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin-1, Nature, 383, 710, 10.1038/383710a0 Citron, 1997, Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice, Nat Med, 3, 67, 10.1038/nm0197-67 St. George-Hyslop, 1990, Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder, Nature, 347, 194, 10.1038/347194a0 Schellenberg, 1992, Genetic linkage evidence for a familial Alzheimer's disease locus on Chromosome 14, Science, 258, 668, 10.1126/science.1411576 Van Broeckhoven, 1992, Mapping of a gene predisposing to early-onset Alzheimer's disease to Chromosome 14q24.3, Nat Genet, 2, 335, 10.1038/ng1292-335 St. George-Hyslop, 1992, Genetic evidence for a novel familial Alzheimer's disease locus on Chromosome 14, Nat Genet, 2, 330, 10.1038/ng1292-330 Mullan, 1992, A locus for Alzheimer's disease on the long arm of Chromosome 14, proximal to the a1-antichymotrypsin gene, Nat Genet, 2, 340, 10.1038/ng1292-340 Kovacs, 1996, Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nat Med, 2, 224, 10.1038/nm0296-224 Li, 1998, Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins, Proc Natl Acad Sci U S A, 95, 7109, 10.1073/pnas.95.12.7109 Thinakaran, 1996, Endoproteolysis of presenilin-1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 Crook, 1997, Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation, Ann Neurol, 42, 124, 10.1002/ana.410420121 Hardy, 2001, Presenilin mutations line up along transmembrane alpha-helices, Neurosci Lett, 306, 203, 10.1016/S0304-3940(01)01910-3 Queralt, 2002, A novel mutation (V89L) in the presenilin-1 gene in a family with early-onset Alzheimer's disease and marked behavioral disturbances, J Neurol Neurosurg Psychiatry, 72, 266, 10.1136/jnnp.72.2.266 Prihar, 1999, A novel candidate presenilin-1-interacting protein containing tetratricopeptide repeats, Neuroreport, 10, 1409, 10.1097/00001756-199905140-00005 Crook, 1998, A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin-1, Nat Med, 4, 452, 10.1038/nm0498-452 Smith, 2001, Variable phenotype of Alzheimer's disease with spastic paraparesis, Ann Neurol, 49, 125, 10.1002/1531-8249(200101)49:1<125::AID-ANA21>3.0.CO;2-1 Houlden, 2000, Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations, Ann Neurol, 48, 806, 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F Perez-Tur, 1995, A mutation in Alzheimer's disease destroying a splice-acceptor site in the presenilin-1 gene, Neuroreport, 7, 297, 10.1097/00001756-199512000-00071 Ishii, 1997, Increased ABeta42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene, Neurosci Lett, 228, 17, 10.1016/S0304-3940(97)00347-9 Sato, 1998, Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease, Hum Mutat, suppl, S91, 10.1002/humu.1380110131 De Jonghe, 1999, Aberrant splicing in the presenilin-1 intron-4 mutation causes presenile Alzheimer's disease by increased ABeta42 secretion, Hum Mol Genet, 8, 1529, 10.1093/hmg/8.8.1529 Rogaeva, 2001, Screening for PS-1 mutations in a referral-based series of AD cases: 21 novel mutations, Neurology, 57, 621, 10.1212/WNL.57.4.621 Moehlmann, 2002, Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on ABeta42 production, Proc Natl Acad Sci U S A, 99, 8025, 10.1073/pnas.112686799 Axelman, 1998, Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene, Arch Neurol, 55, 698, 10.1001/archneur.55.5.698 Janssen, 2001, Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin-1 mutation, Arch Neurol, 58, 953, 10.1001/archneur.58.6.953 Fox, 1997, Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin-1 gene: pedigree but not mutation-specific age at onset provides evidence for a further genetic factor, Brain, 120, 491, 10.1093/brain/120.3.491 Lopera, 1997, Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation, JAMA, 277, 793, 10.1001/jama.1997.03540340027028 Rossor, 1996, Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation, Lancet, 347, 1560, 10.1016/S0140-6736(96)90715-1 Poorkaj, 1998, Missense mutations in the Chromosome 14 familial Alzheimer's disease presenilin-1 gene, Hum Mutat, 11, 216, 10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.0.CO;2-F Levy-Lahad, 1995, Apolipoprotein-E genotypes and age of onset in early-onset familial Alzheimer's disease, Ann Neurol, 38, 678, 10.1002/ana.410380420 Romero, 1999, A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease, Neuroreport, 10, 2255, 10.1097/00001756-199908020-00006 Kwok, 1997, Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype, Neuroreport, 8, 1537, 10.1097/00001756-199704140-00043 Lampe, 1994, Phenotype of Chromosome 14-linked familial Alzheimer's disease in a large kindred, Ann Neurol, 36, 368, 10.1002/ana.410360308 Haltia, 1994, Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description, Ann Neurol, 36, 362, 10.1002/ana.410360307 Bird, 1989, Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds, Ann Neurol, 25, 12, 10.1002/ana.410250104 Kennedy, 1995, Chromosome 14-linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree, Brain, 118, 185, 10.1093/brain/118.1.185 Ezquerra, 1999, A presenilin-1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures, Neurology, 52, 566, 10.1212/WNL.52.3.566 Houlden, 2001, A novel presenilin mutation (M233V) causing very-early-onset Alzheimer's disease with Lewy bodies, Neurosci Lett, 313, 93, 10.1016/S0304-3940(01)02254-6 Mayeux, 1985, Heterogeneity in dementia of the Alzheimer type: evidence of subgroups, Neurology, 35, 453, 10.1212/WNL.35.4.453 Mullan, 1993, Age of onset in familial early-onset Alzheimer's disease correlates with genetic aetiology, Am J Med Genet, 48, 129, 10.1002/ajmg.1320480303 Tedde, 2000, A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset, Neurology, 55, 1590, 10.1212/WNL.55.10.1590 Raux, 2000, Dementia with prominent frontotemporal features associated with L113P presenilin-1 mutation, Neurology, 55, 1577, 10.1212/WNL.55.10.1577 Amtul, 2002, A presenilin-1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch, Neurobiol Dis, 9, 269, 10.1006/nbdi.2001.0473 Finckh, 2000, Variable expression of familial Alzheimer disease associated with presenilin-2 mutation M239I, Neurology, 54, 2006, 10.1212/WNL.54.10.2006 Bird, 1996, Wide range in age of onset for Chromosome 1-related familial Alzheimer's disease, Ann Neurol, 40, 932, 10.1002/ana.410400619 Ezquerra, 2003, A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer's disease, Arch Neurol, 60, 1149, 10.1001/archneur.60.8.1149 Prihar, 1999, Alzheimer disease PS-1 exon 9 deletion defined, Nat Med, 5, 1090, 10.1038/13383 Sodeyama, 2001, Very-early-onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin-1 mutation (Phe237Ile), J Neurol Neurosurg Psychiatry, 71, 556, 10.1136/jnnp.71.4.556 Steiner, 2001, A pathogenic presenilin-1 deletion causes aberrant ABeta42 production in the absence of congophilic amyloid plaques, J Biol Chem, 276, 7233, 10.1074/jbc.M007183200 O'Riordan, 2002, Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities, Neurology, 59, 1108, 10.1212/WNL.59.7.1108 Taddei, 1998, Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very-early-onset Alzheimer's disease, Neuroreport, 9, 3335, 10.1097/00001756-199810050-00034 Matsubara-Tsutsui, 2002, Molecular evidence of presenilin-1 mutation in familial early-onset dementia, Am J Med Genet, 114, 292, 10.1002/ajmg.10250 Assini, 2003, Pure spastic paraparesis associated with a novel presenilin-1 R278K mutation, Neurology, 60, 150, 10.1212/01.WNL.0000040252.43269.83 Verkkoniemi, 2000, Variant Alzheimer's disease with spastic paraparesis: clinical characterization, Neurology, 54, 1103, 10.1212/WNL.54.5.1103 Verkkoniemi, 2001, Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype, J Neuropathol Exp Neurol, 60, 483, 10.1093/jnen/60.5.483 Tabira, 2002, Alzheimer's disease with spastic paresis and cotton wool-type plaques, J Neurosci Res, 70, 367, 10.1002/jnr.10392 Vidal, 1999, A stop-codon mutation in the BRI gene associated with familial British dementia, Nature, 399, 776, 10.1038/21637 Gomez-Isla, 1997, A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes, Ann Neurol, 41, 809, 10.1002/ana.410410618 Mann, 1996, Amyloid beta protein (ABeta) deposition in Chromosome 14-linked Alzheimer's disease: predominance of ABeta42(43), Ann Neurol, 40, 149, 10.1002/ana.410400205 Mann, 2001, Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease, Am J Pathol, 158, 2165, 10.1016/S0002-9440(10)64688-3 Lemere, 1996, The E280A presenilin-1 Alzheimer mutation produces increased ABeta 42 deposition and severe cerebellar pathology, Nat Med, 2, 1146, 10.1038/nm1096-1146 McNamara, 1998, Apolipoprotein-E genotype and deposits of ABeta40 and ABeta42 in Alzheimer disease, Arch Neurol, 55, 1001, 10.1001/archneur.55.7.1001 Lippa, 1998, Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes, Am J Pathol, 153, 1365, 10.1016/S0002-9440(10)65722-7 Lippa, 2001, Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease, Arch Neurol, 58, 1817, 10.1001/archneur.58.11.1817 Le, 2001, Cottonwool plaques in non-familial late-onset Alzheimer disease, J Neuropathol Exp Neurol, 60, 1051, 10.1093/jnen/60.11.1051 Ikeda, 1996, The clinical phenotype of two missense mutations in the presenilin-1 gene in Japanese patients, Ann Neurol, 40, 912, 10.1002/ana.410400614 De Jonghe, 1999, Evidence that ABeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype, Neurobiol Dis, 6, 280, 10.1006/nbdi.1999.0247 Murayama, 1999, Enhancement of amyloid beta 42 secretion by 28 different presenilin-1 mutations of familial Alzheimer's disease, Neurosci Lett, 265, 61, 10.1016/S0304-3940(99)00187-1 Xia, 1997, Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins, J Biol Chem, 272, 7977, 10.1074/jbc.272.12.7977 Borchelt, 1996, Familial Alzheimer's disease-linked presenilin-1 variants elevate ABeta1–42/1–40 ratio in vitro and in vivo, Neuron, 17, 1005, 10.1016/S0896-6273(00)80230-5 Vanderhoeven, 1999, Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143T and G384A mutations, Neurosci Lett, 274, 183, 10.1016/S0304-3940(99)00722-3 Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity, Nature, 398, 513, 10.1038/19077 Murphy, 2000, Presenilin-1 regulates pharmacologically distinct gamma-secretase activities implications for the role of presenilin in gamma-secretase cleavage, J Biol Chem, 275, 26277, 10.1074/jbc.M002812200 Iwatsubo, 1994, Visualization of ABeta 42(43) and ABeta 40 in senile plaques with end-specific ABeta monoclonals: evidence that an initially deposited species is ABeta 42(43), Neuron, 13, 45, 10.1016/0896-6273(94)90458-8 Guo, 1997, Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals, J Neurosci, 17, 4212, 10.1523/JNEUROSCI.17-11-04212.1997 Guo, 1999, Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation, J Neurochem, 72, 1019, 10.1046/j.1471-4159.1999.0721019.x Katayama, 1999, Presenilin-1 mutations downregulate the signaling pathway of the unfolded-protein response, Nat Cell Biol, 1, 479, 10.1038/70265 Milhavet, 2002, Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations, J Neurochem, 83, 673, 10.1046/j.1471-4159.2002.01165.x Sato, 2000, Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression, Nat Cell Biol, 2, 863, 10.1038/35046500 Siman, 2001, Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation, J Biol Chem, 276, 44736, 10.1074/jbc.M104092200 Kimberly, 2003, Gamma-secretase is a membrane protein complex composed of presenilin, nicastrin, aph-1, and pen-2, Proc Natl Acad Sci U S A, 10.1073/pnas.1037392100 Yu, 2000, Nicastrin modulates presenilin-mediated Notch/glp-1 signal transduction and beta-APP processing, Nature, 407, 48, 10.1038/35024009 Cao, 2001, A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, 293, 115, 10.1126/science.1058783 Gao, 2001, The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus, Proc Natl Acad Sci U S A, 98, 14979, 10.1073/pnas.261463298 Kinoshita, 2002, Direct visualization of the gamma-secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus, J Neurochem, 82, 839, 10.1046/j.1471-4159.2002.01016.x Cupers, 2001, The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture, J Neurochem, 78, 1168, 10.1046/j.1471-4159.2001.00516.x Artavanis-Tsanokas, 1999, Notch signaling: cell fate control and signal integration in development, Science, 284, 770, 10.1126/science.284.5415.770 Fortini, 2002, Gamma-secretase-mediated proteolysis in cell-surface-receptor signaling, Nat Rev Neurosci, 3, 673, 10.1038/nrm910 Berezovska, 1999, Notch1 inhibits neurite outgrowth in postmitotic primary neurons, Neuroscience, 93, 433, 10.1016/S0306-4522(99)00157-8 Berezovska, 1998, Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease, J Neuropathol Exp Neurol, 57, 738, 10.1097/00005072-199808000-00003 Jack, 2001, Effect of PS-1 deficiency and an APP gamma-secretase inhibitor on Notch1 signaling in primary mammalian neurons, Brain Res Mol Brain Res, 87, 166, 10.1016/S0169-328X(01)00010-9 Berezovska, 2000, Aspartate mutations in presenilin and gamma-secretase inhibitors both impair Notch 1 proteolysis and nuclear translocation with relative preservation of Notch 1 signaling, J Neurochem, 75, 583, 10.1046/j.1471-4159.2000.0750583.x Levitan, 1995, Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene, Nature, 377, 351, 10.1038/377351a0 Ponting, 2002, Identification of a novel family of presenilin homologues, Hum Mol Genet, 11, 1037, 10.1093/hmg/11.9.1037 Murayama, 1997, Different effects of Alzheimer-associated mutations of presenilin-1 on its processing, Neurosci Lett, 229, 61, 10.1016/S0304-3940(97)00417-5 Hutton, 1996, Complete analysis of the presenilin-1 gene in early-onset Alzheimer's disease, Neuroreport, 7, 801, 10.1097/00001756-199602290-00029 Cruts, 1995, Molecular genetic analysis of familial early-onset Alzheimer's disease linked to Chromosome 14q24.3, Hum Mol Genet, 4, 2363, 10.1093/hmg/4.12.2363 Martin, 1991, Early-onset Alzheimer's disease in two large Belgian families, Neurology, 41, 62, 10.1212/WNL.41.1.62 Alzheimer's Disease Collaborative Group, 1995, The structure of the presenilin-1 (S182) gene and identification of six novel mutations in early-onset AD families, Nat Genet, 11, 219, 10.1038/ng1095-219 Sorbi, 1995, Missense mutations of S182 gene in Italian families with early-onset Alzheimer's disease, Lancet, 346, 439, 10.1016/S0140-6736(95)92809-X Ezquerra, 2000, A novel presenilin-1 mutation (Leu166Arg) associated with early-onset Alzheimer disease, Arch Neurol, 57, 485, 10.1001/archneur.57.4.485 Harvey, 1998, Chromosome-14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine > serine (L250S) substitution at codon 250 of the presenilin-1 gene, J Neurol Neurosurg Psychiatry, 64, 44, 10.1136/jnnp.64.1.44 Chapman, 1995, Familial Alzheimer's disease associated with S182 codon 286 mutation, Lancet, 346, 1040, 10.1016/S0140-6736(95)91723-3 Vassar, 2000, ABeta-generating enzymes: recent advances in beta- and gamma-secretase research, Neuron, 27, 419, 10.1016/S0896-6273(00)00051-9 Lammich, 2002, Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an ABeta-like peptide, J Biol Chem, 277, 44754, 10.1074/jbc.M206872200 Baki, 2001, Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex, Proc Natl Acad Sci U S A, 98, 2381, 10.1073/pnas.041603398 Marambaud, 2002, A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions, EMBO J, 21, 1948, 10.1093/emboj/21.8.1948 Ni, 2001, Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase, Science, 294, 2179, 10.1126/science.1065412 Lee, 2002, Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4, J Biol Chem, 277, 6318, 10.1074/jbc.M110371200 May, 2002, Proteolytic processing of low-density lipoprotein receptor-related protein mediates regulated release of its intracellular domain, J Biol Chem, 277, 18736, 10.1074/jbc.M201979200 Kim, 2002, Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage, J Biol Chem, 277, 49976, 10.1074/jbc.M210179200 De Strooper, 1999, A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain, Nature, 398, 518, 10.1038/19083